Literature DB >> 10507759

Syrian hamster dermal cell immortalization is not enhanced by power line frequency electromagnetic field exposure.

S C Gamble1, H Wolff, J E Arrand.   

Abstract

Several epidemiological studies have suggested associations between exposure to residential power line frequency electromagnetic fields and childhood leukaemia, and between occupational exposure and adult leukaemia. A variety of in vitro studies have provided limited supporting evidence for the role of such exposures in cancer induction in the form of acknowledged cellular end points, such as enhanced mutation rate and cell proliferation, though the former is seen only with extremely high flux density exposure or with co-exposure to ionizing radiation. However, in vitro experiments on a scale large enough to detect rare cancer-initiating events, such as primary cell immortalization following residential level exposures, have not thus far been reported. In this study, large cultures of primary Syrian hamster dermal cells were continuously exposed to power line frequency electromagnetic fields of 10 100 and 1000 microT for 60 h, with and without prior exposure to a threshold (1.5 Gy), or sub-threshold (0.5 Gy), immortalizing dose of ionizing radiation. Electromagnetic field exposure alone did not immortalize these cells at a detectable frequency (> or = 1 x 10(-7)); furthermore, such exposure did not enhance the frequency of ionizing radiation-induced immortalization.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10507759      PMCID: PMC2362933          DOI: 10.1038/sj.bjc.6690704

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  22 in total

1.  Increase in radiation-induced HPRT gene mutation frequency after nonthermal exposure to nonionizing 60 Hz electromagnetic fields.

Authors:  J Walleczek; E C Shiu; G M Hahn
Journal:  Radiat Res       Date:  1999-04       Impact factor: 2.841

2.  Extremely low frequency pulsed electromagnetic fields increase cell proliferation in lymphocytes from young and aged subjects.

Authors:  A Cossarizza; D Monti; F Bersani; M Cantini; R Cadossi; A Sacchi; C Franceschi
Journal:  Biochem Biophys Res Commun       Date:  1989-04-28       Impact factor: 3.575

3.  Electrical wiring configurations and childhood cancer.

Authors:  N Wertheimer; E Leeper
Journal:  Am J Epidemiol       Date:  1979-03       Impact factor: 4.897

4.  Neoplastic transformation of C3H/10T1/2 cells following exposure to 120-Hz modulated 2.45-GHz microwaves and phorbol ester tumor promoter.

Authors:  E K Balcer-Kubiczek; G H Harrison
Journal:  Radiat Res       Date:  1991-04       Impact factor: 2.841

5.  Occupational exposure to electromagnetic fields in relation to leukemia and brain tumors: a case-control study in Sweden.

Authors:  B Floderus; T Persson; C Stenlund; A Wennberg; A Ost; B Knave
Journal:  Cancer Causes Control       Date:  1993-09       Impact factor: 2.506

6.  Magnetic fields and cancer in children residing near Swedish high-voltage power lines.

Authors:  M Feychting; A Ahlbom
Journal:  Am J Epidemiol       Date:  1993-10-01       Impact factor: 4.897

7.  Case-control study of childhood cancer and exposure to 60-Hz magnetic fields.

Authors:  D A Savitz; H Wachtel; F A Barnes; E M John; J G Tvrdik
Journal:  Am J Epidemiol       Date:  1988-07       Impact factor: 4.897

8.  Mechanisms involved in the immortalization of mammalian cells by ionizing radiation and chemical carcinogens.

Authors:  D A Trott; A P Cuthbert; R W Overell; I Russo; R F Newbold
Journal:  Carcinogenesis       Date:  1995-02       Impact factor: 4.944

9.  Short exposures to 60 Hz magnetic fields do not alter MYC expression in HL60 or Daudi cells.

Authors:  J D Saffer; S J Thurston
Journal:  Radiat Res       Date:  1995-10       Impact factor: 2.841

10.  No effect of 60 Hz electromagnetic fields on MYC or beta-actin expression in human leukemic cells.

Authors:  A Lacy-Hulbert; R C Wilkins; T R Hesketh; J C Metcalfe
Journal:  Radiat Res       Date:  1995-10       Impact factor: 2.841

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.